Inventor · name-matched record
WEISS DAHLIA
2 granted patents·1 pending application·0 citations·filing 2021–2025
26Inventor score
Technology areasC07D
Files withNURIX THERAPEUTICS INC3
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
3 records- 0188US2026035378A1Bifunctional compounds for degrading btk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0281US12583862B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2023·Granted Mar 24, 2026·0 cites·19 claims
- 0354US12528814B2Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereofNURIX THERAPEUTICS INC·Filed 2021·Granted Jan 20, 2026·0 cites·57 claims
Join the waitlist — get patent alerts
Get an alert when WEISS DAHLIA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →